Clinical trial
Prospective Study to Evaluate the Clinical Utility of Perioperative Pharmacogenomic Testing
NCT03531268 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study to Evaluate the Clinical Utility of Perioperative Pharmacogenomic Testing
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- October 20, 2018
- Completion date
- May 20, 2020
- Enrollment
- 0 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
perioperative/postoperative complications